BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34064703)

  • 1. Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021.
    Shim E
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34064703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic.
    Newall AT; Leong RNF; Nazareno A; Muscatello DJ; Wood JG; Kim WJ
    Int J Infect Dis; 2020 Dec; 101():306-311. PubMed ID: 33011281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-stratified analysis of SARS-CoV-2 infection and case fatality rate in China, Italy, and South Korea.
    Liu JQ; Xu JW; Sun CY; Wang JN; Wang XT; Chen X; Gao SL
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12575-12578. PubMed ID: 33336777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020.
    Undurraga EA; Chowell G; Mizumoto K
    Infect Dis Poverty; 2021 Feb; 10(1):11. PubMed ID: 33531085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The confounded crude case-fatality rates (CFR) for COVID-19 hide more than they reveal-a comparison of age-specific and age-adjusted CFRs between seven countries.
    Green MS; Peer V; Schwartz N; Nitzan D
    PLoS One; 2020; 15(10):e0241031. PubMed ID: 33085731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in South Korea: epidemiological and spatiotemporal patterns of the spread and the role of aggressive diagnostic tests in the early phase.
    Lee W; Hwang SS; Song I; Park C; Kim H; Song IK; Choi HM; Prifti K; Kwon Y; Kim J; Oh S; Yang J; Cha M; Kim Y; Bell ML; Kim H
    Int J Epidemiol; 2020 Aug; 49(4):1106-1116. PubMed ID: 32754756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: factors associated with increased case-fatality rates.
    Monterrubio-Flores E; Ramírez-Villalobos MD; Espinosa-Montero J; Hernandez B; Barquera S; Villalobos-Daniel VE; Campos-Nonato I
    Int J Epidemiol; 2021 May; 50(2):430-445. PubMed ID: 33585901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States.
    Abdollahi E; Champredon D; Langley JM; Galvani AP; Moghadas SM
    CMAJ; 2020 Jun; 192(25):E666-E670. PubMed ID: 32444481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries : A Nine-Country Demographic Study.
    Sudharsanan N; Didzun O; Bärnighausen T; Geldsetzer P
    Ann Intern Med; 2020 Nov; 173(9):714-720. PubMed ID: 32698605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the Risk of COVID-19 Death During the Course of the Outbreak in Korea, February-May 2020.
    Shim E; Mizumoto K; Choi W; Chowell G
    J Clin Med; 2020 May; 9(6):. PubMed ID: 32485871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.
    Shi HJ; Yang J; Eom JS; Ko JH; Peck KR; Kim UJ; Jung SI; Kim S; Seok H; Hyun M; Kim HA; Kim B; Joo EJ; Cheong HS; Jun CH; Wi YM; Kim J; Kym S; Lim S; Park Y
    J Korean Med Sci; 2023 Jul; 38(28):e217. PubMed ID: 37463688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission potential and severity of COVID-19 in South Korea.
    Shim E; Tariq A; Choi W; Lee Y; Chowell G
    Int J Infect Dis; 2020 Apr; 93():339-344. PubMed ID: 32198088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring trends and differences in COVID-19 case-fatality rates using decomposition methods: Contributions of age structure and age-specific fatality.
    Dudel C; Riffe T; Acosta E; van Raalte A; Strozza C; Myrskylä M
    PLoS One; 2020; 15(9):e0238904. PubMed ID: 32913365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020.
    Korean Society of Infectious Diseases and Korea Centers for Disease Control and Prevention
    J Korean Med Sci; 2020 Mar; 35(12):e132. PubMed ID: 32233161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation Between Third Dose of COVID-19 Vaccines and Regional Case Fatality Rates During the Omicron Wave in Korea.
    Jang Y; Kim IJ; Moon SS; Kim SB; Lee J
    J Korean Med Sci; 2022 Dec; 37(50):e347. PubMed ID: 36573384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    Hauser A; Counotte MJ; Margossian CC; Konstantinoudis G; Low N; Althaus CL; Riou J
    PLoS Med; 2020 Jul; 17(7):e1003189. PubMed ID: 32722715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional Variability in COVID-19 Case Fatality Rate in Canada, February-December 2020.
    Shim E
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada.
    Hoffmann C; Wolf E
    Infection; 2021 Feb; 49(1):111-116. PubMed ID: 33098532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status.
    Lai CC; Wang CY; Wang YH; Hsueh SC; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105946. PubMed ID: 32199877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demystifying the varying case fatality rates (CFR) of COVID-19 in India: Lessons learned and future directions.
    Asirvatham ES; Lakshmanan J; Sarman CJ; Joy M
    J Infect Dev Ctries; 2020 Oct; 14(10):1128-1135. PubMed ID: 33175707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.